Technology
LUMEDX Corp. offers the CardioPACS 5.0, the latest version of its cardiology PACS software. The multi-modality, Web-enabled and vendor-neutral CardioPACS 5.0 offers new and better ways to manage images and data with a fully integrated suite of applications, modules.
July 13, 2008
News
July 14, 2008 - Micrus Endovascular Corp. today said the Pharos Vitesse Intracranial Stent Study for Ischemic Therapy ...
July 13, 2008News
July 14, 2008 – The Access to Medical Imaging Coalition (AMIC) said in a statement today, "A report from the Government Accountability Office (GAO) that recommends Medicare adopt prior authorization criteria to address appropriate utilization of medical imaging services was constructed on an incomplete analysis and should not be used by policymakers to make coverage decisions."
July 13, 2008Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
July 11, 2008 - Micrus Endovascular Corp. said this week it received approval from the Ministry of Health, Labour and Welfare (MHLW) to market in Japan the Cerecyte microcoil product line, including the MicruSphere, Presidio, HeliPaq and UltiPaq Cerecyte embolic coils, for the endovascular treatment of cerebral aneurysms.
July 10, 2008
Technology
AngioScore Inc. has introduced longer and larger AngioSculpt PTA Scoring Balloon Catheters for the treatment of peripheral artery disease (PAD).
July 10, 2008News
July 11, 2008 - St. Jude Medical Inc. today received European CE Mark approval and began its European launch of its line ...
July 10, 2008Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
July 11, 2008 - Bioheart Inc. this week said it secured worldwide, nonexclusive distribution rights to the Bioheart 3370 ...
July 10, 2008News
July 11, 2008 - A new study that found wireless systems that track hospital medical equipment can cause potentially hazardous incidents involving lifesaving devices may have caused needless alarmed, says a biomedical engineering technology professor at Indiana University-Purdue University Indianapolis (IUPUI).
July 10, 2008Technology
Bioheart Inc. offers the Bioheart 3370 Heart Failure Monitor, an interactive and simple-to-use at-home device designed to better monitor patients outside hospitals who are suffering from heart failure. The device, manufactured by RTX Healthcare A/S of Denmark, has FDA 510(k) market clearance and CE Mark in Europe.
July 10, 2008Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
July 11, 2008 - AngioScore Inc. today announced the launch of new longer and larger AngioSculpt PTA Scoring Balloon ...
July 10, 2008
Feature | Archana Swathy, Research Analyst, Frost & Sullivan
Physicians recognize the importance of ventricular assist devices (VADs) every time a congestive heart failure (CHF) ...
July 09, 2008News
July 10, 2008 - Boston Scientific Corp. this week launched its Atlantis .018 Peripheral Imaging Catheter, which reportedly brings existing 40 MHz coronary standard ultrasound imaging resolution to peripheral interventions. The company said the product is available for immediately release in the U.S.
July 09, 2008Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Feature | Richard R. Rogoski
Preliminary results of a multicenter study show that the use of tiny clips to repair the mitral valve may someday ...
July 09, 2008News
July 10, 2008 - Datascope Corp. said today it exercised its option to acquire the Peripheral Vascular Stent business of ...
July 09, 2008
Feature | Nick Obradovich
The only safe assumption to make about today’s current gold standard imaging modality used to identify and evaluate atheromatous plaque in the peripheral arteries is that there is not one gold standard. To locate and evaluate these plaques that cause peripheral vascular disease (PVD), physicians have multiple tried-and-true imaging tests at their disposal.
July 09, 2008© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now